Sign in

NCT03301792Active, not recruiting

Group Versus Traditional Prenatal Care for Diabetes

Group Versus Traditional Prenatal Care for Diabetes: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 21 Aug 2026

Brief summary (registry, in English)

The investigators primary objective is to conduct a randomized trial to determine the effect of diabetes group prenatal care on glycemic control and postpartum weight retention in women with type 2 diabetes and gestational diabetes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
117 (estimated)
First submitted
15 Sept 2017
Start date
14 Sept 2017
Primary completion date
17 Nov 2025
Lead sponsor
Washington University School of Medicine
NCT number
NCT03301792

What you commit to

  • Study type: Interventional
  • Planned participants: 117
  • From 14 Sept 2017 to the primary completion date, 17 Nov 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior participation in diabetes group care

Other illness

  • Type 1 Diabetes
  • Serious psychiatric illness including schizophrenia necessitating more care than can safely be provided in group setting, as deemed by medical provider.

Other

  • Multiple gestation
  • Major fetal anomaly
  • Serious medical co-morbidity necessitating more care than can be safely provided in group setting, as deemed by medical provider.

Who the study is looking for

  • English speaking
  • Type 2 diabetes OR gestational diabetes diagnosed by 2-step method(1) OR likely pre-existing Type 2 diabetes with one of the following during pregnancy and \</= 34 weeks:
    • 1 hour glucose challenge test \>/= 185mg/dL OR
    • A1c \>/= 6.5% OR
    • Fasting plasma glucose \> 126mg/dL (2)
  • Ability to attend group prenatal visit at specified days and times
  • Willingness to be randomized at 22 weeks 0 days-34 weeks 0 days OR initial visit between 24 weeks 0 days-34 weeks 0 days
  • Ability to give informed consent

Age in the registry: 18 years to 50 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Utah
Coordinator of this site? Confirm its status
Salt Lake CityUnited StatesUnknown status
Washington University in St. Louis
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.